| Top 5 Stories : |
 |
Med Man: A New York Pharma Exec, 1960
It's strange to think that the industry as we know it now began only about 20 years ago. It wasn't until after WWII that the wonder drugs really took off. Before that, no ethical drug manufacturer could boast a sales volume even as large as Macy’s department store.
Read more
|
|
|
|
|
|
 |
Pricing's Point Man
Despite its underlying importance to the very survival of the R&D industry, market access has not received the attention it deserves as a living, strategic function, with its own embellished litany of shared learnings and “best practices.”
Read more
|
|
|
Digital Marketing According to HIPAA
Pharmaceutical marketers need to find a new way to offer modern, personalized marketing content that will help them get their message across to the right people, but remain HIPAA compliant at the same time.
Read more
|
|
|
| Trending on Social Media : |
Is There Gold in the DNA Selfie?
Not much is known about the growing prominence of patient organizations in the crowded and intensely competitive business of scientific research.
Read more
|
#WMIF15’s Disruptive Dozen
Neuroscience luminaries clamored onto the stage at yesterday’s World Medical Innovation Forum in Boston to present the meeting’s much-anticipated Disruptive Dozen.
Read more
|
The Power of Proactive Pharmacovigilance
Greater public awareness of drug safety issues and emerging informatics-based methods for acquiring and analyzing medical information, have sparked global initiatives to transform the current largely reactive safety system into one that is proactive, robust, and more useful clinically.
Read more
|
|
|
| Follow Us |
|
|
|
|
